Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

BACKGROUND: Non-vitamin K antagonist oral anticoagulants, including dabigatran, are currently widely used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Recently, idarucizumab, a monoclonal antibody fragment for immediate reversal of dabigatran-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Case Rep
Hlavní autoři: Agosti, Sergio, Casalino, Laura, Rocci, Enrico, Zaccone, Gabriele, Rota, Eugenia
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557536/
https://ncbi.nlm.nih.gov/pubmed/28806993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-017-1404-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky